Author:
Pinazo-Durán M.D.,Zanón-Moreno V.,Herrero Vanrell R.,Sanz-González S.M.,García-Medina J.J.,Benitez del Castillo Sánchez J.
Reference12 articles.
1. Eclectic ocular comorbidities and systemic diseases with eye involvement: A review;Pinazo-Durán;Biomed Res Int,2016
2. Managing treatment side effects: The respective roles of the active ingredient and the preservative;Aptel;J Fr Ophtalmol,2011
3. Orden SSI/23/2015, de 15 de enero, por la que se aprueba la quinta edición de la Real Farmacopea Española. (BOE núm. 18 de 21 de enero de 2015).
4. Therapeutic effects of sodium hyaluronate on ocular surface damage induced by benzalkonium chloride preserved anti-glaucoma medications;Liu;Chin Med J (Engl),2015
5. In vivo distribution of corneal epithelial dendritic cells in patients with glaucoma;Mastropasqua;Invest Ophthalmol Vis Sci,2016